326 related articles for article (PubMed ID: 17141355)
21. Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians.
Pereira JA; Holbrook AM; Dolovich L; Goldsmith C; Thabane L; Douketis JD; Crowther M; Bates SM; Ginsberg JS
Can J Clin Pharmacol; 2005; 12(3):e229-39. PubMed ID: 16278495
[TBL] [Abstract][Full Text] [Related]
22. A pilot study on generic medicine substitution practices among community pharmacists in the State of Penang, Malaysia.
Ping CC; Bahari MB; Hassali MA
Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):82-9. PubMed ID: 17879323
[TBL] [Abstract][Full Text] [Related]
23. Factors facilitating and hindering counselling about generic substitution and a reference price system in community pharmacies - a survey among Finnish dispensers.
Rainio R; Ahonen R; Lämsä E; Timonen J
BMC Health Serv Res; 2022 Sep; 22(1):1130. PubMed ID: 36071413
[TBL] [Abstract][Full Text] [Related]
24. Trends of generic substitution in community pharmacies.
Suh DC
Pharm World Sci; 1999 Dec; 21(6):260-5. PubMed ID: 10658234
[TBL] [Abstract][Full Text] [Related]
25. Physicians' attitudes toward and knowledge about generic drug substitution.
Friedman D; Jaffe A; Steinhardt S
N Y State J Med; 1987 Oct; 87(10):539-42. PubMed ID: 3479720
[No Abstract] [Full Text] [Related]
26. Generic medicines: Greek physicians' perceptions and prescribing practices.
Tsiantou V; Zavras D; Kousoulakou H; Geitona M; Kyriopoulos J
J Clin Pharm Ther; 2009 Oct; 34(5):547-54. PubMed ID: 19744010
[TBL] [Abstract][Full Text] [Related]
27. The impact of generic substitution on price competition in Finland.
Aalto-Setälä V
Eur J Health Econ; 2008 May; 9(2):185-91. PubMed ID: 17508226
[TBL] [Abstract][Full Text] [Related]
28. Pharmacy customers' knowledge of side effects of purchased medicines in Mexico.
Wirtz VJ; Taxis K; Dreser A
Trop Med Int Health; 2009 Jan; 14(1):93-100. PubMed ID: 19017308
[TBL] [Abstract][Full Text] [Related]
29. Physicians' attitudes toward generic drug substitution by pharmacists.
Brust M; Hawkins CF; Grayson D
Tex Med; 1990 Mar; 86(3):45-9. PubMed ID: 2333636
[TBL] [Abstract][Full Text] [Related]
30. Generic substitution: additional challenge for adherence in hypertensive patients?
Håkonsen H; Eilertsen M; Borge H; Toverud EL
Curr Med Res Opin; 2009 Oct; 25(10):2515-21. PubMed ID: 19708764
[TBL] [Abstract][Full Text] [Related]
31. [Fifty years old and more patients' attitudes towards and experiences of generic substitution of prescription medicines].
Ringuier R; Rouquette A; Dagorne C; Garnier F; Fanello S
Therapie; 2008; 63(1):11-7. PubMed ID: 18387271
[TBL] [Abstract][Full Text] [Related]
32. Finnish physicians show little support for consumer advertising of prescription drugs.
Toivianen H; Vuorenkoski L; Hemminki E
N Z Med J; 2004 Jun; 117(1195):U907. PubMed ID: 15282621
[TBL] [Abstract][Full Text] [Related]
33. Generic substitution in the treatment of epilepsy: patient and physician perceptions.
Berg MJ; Gross RA; Haskins LS; Zingaro WM; Tomaszewski KJ
Epilepsy Behav; 2008 Nov; 13(4):693-9. PubMed ID: 18589000
[TBL] [Abstract][Full Text] [Related]
34. The impact of generic substitution on the activities of pharmaceutical companies - a survey from the companies' perspective one year and five years after the introduction of generic substitution in finland.
Timonen J; Bengtström M; Karttunen P; Ahonen R
BMC Clin Pharmacol; 2010 Oct; 10():15. PubMed ID: 20964869
[TBL] [Abstract][Full Text] [Related]
35. Analysis of pharmacists' opinions, attitudes and experiences with generic drugs and generic substitution in the Czech Republic.
Maly J; Dosedel M; Kubena A; Vlcek J
Acta Pol Pharm; 2013; 70(5):923-31. PubMed ID: 24147373
[TBL] [Abstract][Full Text] [Related]
36. The impact of generic substitution on the turnover and gross margin of pharmaceutical companies a survey 1 year and 5 years after the introduction of generic substitution in Finland.
Timonen J; Karttunen P; Bengtström M; Ahonen R
Health Policy; 2009 Oct; 92(2-3):116-23. PubMed ID: 19346023
[TBL] [Abstract][Full Text] [Related]
37. Exploring the opinions and experiences of patients with generic substitution: a representative study of Polish society.
Drozdowska A; Hermanowski T
Int J Clin Pharm; 2015 Feb; 37(1):68-75. PubMed ID: 25428446
[TBL] [Abstract][Full Text] [Related]
38. Generic warfarin: implications for clinical practice and perceptions of anticoagulation providers.
Bongiorno RA; Nutescu EA
Semin Thromb Hemost; 2004 Dec; 30(6):619-26. PubMed ID: 15630667
[TBL] [Abstract][Full Text] [Related]
39. Current approaches to the use of generic antiepileptic drugs.
Krämer G; Biraben A; Carreno M; Guekht A; de Haan GJ; Jedrzejczak J; Josephs D; van Rijckevorsel K; Zaccara G
Epilepsy Behav; 2007 Aug; 11(1):46-52. PubMed ID: 17537678
[TBL] [Abstract][Full Text] [Related]
40. Pharmacy customers' experiences with the national online service for viewing electronic prescriptions in Finland.
Lämsä E; Timonen J; Mäntyselkä P; Ahonen R
Int J Med Inform; 2017 Jan; 97():221-228. PubMed ID: 27919380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
